Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of an Anti-Fungal Supplement
Conditions
Interventions
CanXida Remove (Formula RMV)
Placebo
Locations
1
United States
Citruslabs
Santa Monica, California, United States
Start Date
November 30, 2023
Primary Completion Date
June 28, 2024
Completion Date
June 28, 2024
Last Updated
August 22, 2024
NCT07303101
NCT05908682
NCT07245563
NCT06954493
NCT06788782
NCT03630770
Lead Sponsor
CanXida
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions